An Evaluation of Activity Trackers for Monitoring Parkinson's Disease Patient Outcomes

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease in America. PD results in adverse outcomes including motor impairments and non-motor impairments such as cognition and sleep. Medication has a limited impact on treating PD and slowing down the progression of the disease. Anecdotal reports and some research show that intensive activity has been beneficial not only to slow down the progression of PD, but also may reverse the onset of more severe PD symptoms.